10x Genomics TXG reported its Q4 earnings results on Thursday, February 15, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
10x Genomics beat estimated earnings by 33.33%, reporting an EPS of $-0.24 versus an estimate of $-0.36.
Revenue was up $27.75 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 8.73% increase in the share price the next day.
Here's a look at 10x Genomics's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -0.46 | -0.39 | -0.37 | -0.31 |
EPS Actual | -0.44 | -0.53 | -0.44 | -0.15 |
Revenue Estimate | 151.26M | 138.97M | 128.82M | 148.69M |
Revenue Actual | 153.64M | 146.82M | 134.28M | 156.23M |
To track all earnings releases for 10x Genomics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.